Skip to main content
VCbacked
Log inGet Started

Daisy Genomics

Carlsbad, United States

Daisy Genomics is an medtech focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications.

$2.5M raised
Dec 2025
Seed
BiotechnologyInformation TechnologyMedicalPrecision Medicine

Top Investors

Cottonwood Technology FundSun Mountain CapitalNew Mexico Vintage FundWaves Capital PartnersHamamatsu Photonics

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Daisy Genomics

How much funding has Daisy Genomics raised?
Daisy Genomics has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Who are Daisy Genomics's investors?
Daisy Genomics's investors include Cottonwood Technology Fund, Sun Mountain Capital, New Mexico Vintage Fund, Waves Capital Partners, Hamamatsu Photonics.
Where is Daisy Genomics headquartered?
Daisy Genomics is headquartered in Carlsbad, United States.
What does Daisy Genomics do?
Daisy Genomics is an medtech focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications.
What stage is Daisy Genomics at?
Daisy Genomics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Daisy Genomics — Funding & Investors." VCBacked, December 17, 2025, https://www.vcbacked.co/company/daisy-genomics. Accessed June 17, 2026.
APA
VCBacked. (2025). Daisy Genomics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/daisy-genomics
Wikipedia (cite web)
{{cite web |title=Daisy Genomics — Funding & Investors |url=https://www.vcbacked.co/company/daisy-genomics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong